|
1
|
Kurzrock R, Kantarjian HM, Druker BJ and
Talpaz M: Philadelphia chromosome-positive leukemias: From basic
mechanisms to molecular therapeutics. Ann Intern Med. 138:819–830.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heim S and Mitelman F: Chronic Myeloid
LeukemiaCancer cytogenetics. 3rd. Wiley Blackwell, John Wiley &
Sons, Inc.; Hoboken, NJ: pp. 179–208. 2009
|
|
3
|
Luatti S, Castagnetti F, Marzocchi G,
Baldazzi C, Gugliotta G, Iacobucci I, Specchia G, Zanatta F,
Rege-Cambrin G, Mancini M, et al: Additional chromosomal
abnormalities in Philadelphia-positive clone: Adverse prognostic
influence on frontline imatinib therapy: A GIMEMA. Working Party on
CML analysis. Blood. 120:761–767. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sokal JE, Gomez GA, Baccarani M, Tura S,
Clarkson BD, Cervantes F, Rozman C, Carbonell F, Anger B and
Heimpel H: Prognostic significance of additional cytogenetic
abnormalities at diagnosis of Philadelphia chromosome-positive
chronic granulocytic leukemia. Blood. 72:294–298. 1998.
|
|
5
|
Baccarani M, Cortes J, Pane F,
Niederwieser D, Saglio G, Apperley J, Cervantes F, Deininger M,
Gratwohl A, Guilhot F, et al: Chronic myeloid leukemia: An update
of concepts and management recommendations of European LeukemiaNet.
J Clin Oncol. 27:6041–6051. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Braekeleer E, Meyer C, Douet-Guilbert
N, Morel F, Le Bris MJ, Berthou C, Arnaud B, Marschalek R, Férec C
and De Braekeleer M: Complex and cryptic chromosomal rearrangements
involving the MLL gene in acute leukemia: A study of 7 patients and
review of the literature. Blood Cells Mol Dis. 44:268–274. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Czepulkowski B, Bhatt B and Rooney D:
Analysis of Chromosomes from Bone marrow and Leukaemic Blood. In:
Human cytogenetics. A practical approachMalignancy and acquired
abnormalities. 2. 2nd. Oxford University Press; New York, NY: pp.
1–25. 1992
|
|
8
|
van Dongen JJ, Macintyre EA, Gabert JA,
Delabess E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G,
Griesinger F, et al: Standardized RT-PCR analysis of fusion gene
transcripts from chromosome aberrations in acute leukemia for
detection of minimal residual disease. Report of the BIOMED-1
Concerted Action: Investigation of minimal residual disease in
acute leukemia. Leukemia. 13:1901–1928. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gorre ME, Mohammed M, Ellwood K, Hsu N,
Paquette R, Rao PN and Sawyers CL: Clinical resistance STI-571
Cancer Therapy caused by BCR ABL gene mutation or amplification.
Science. 293:876–880. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stedum SV and King W: Basic FISH
Techniques and Troubleshooting. In: Molecular cytogenetics:
Protocols and applicationsMethods in Molecular Biology. Fan YS:
204. Humana Press; Totowa, NJ: pp. 51–67. 2002, PubMed/NCBI
|
|
11
|
Baccarani M, Deininger MW, Rosti G,
Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes
JE, Guilhot F, et al: European LeukemiaNet recommendations for the
management of chronic myeloid leukemia: 2013. Blood. 122:872–884.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Marin D, Milojkovic D, Olavarria E,
Khorashad JS, de Lavallade H, Reid AG, Foroni L, Rezvani K, Bua M,
Dazzi F, et al: European LeukemiaNet criteria for failure or
suboptimal response reliably identify patients with CML in early
chronic phase treated with imatinib whose eventual outcome is poor.
Blood. 112:4437–4444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fabarius A, Kalmanti L, Dietz CT, Lauseker
M, Rinaldetti S, Haferlach C, Göhring G, Schlegelberger B,
Jotterand M, Hanfstein B, et al: Impact of unbalanced minor route
versus major route karyotypes at diagnosis on prognosis of CML. Ann
Hematol. 94:2015–2024. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rowley JD: The Critical role of chromosome
translocations in human leukemias. Annual Review of Genetics.
32:495–519. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Collongen Rame MA: The t(1;11)(q21;q23).
Atlas Genet Cytogenet Oncol Haematol. 10:125–126. 2006.
|
|
16
|
Sessarego M, Frassoni F, Defferrari R,
Bacigalupo A, Fugazza G, Mareni C, Bruzzone R, Dejana A and Ajmar
F: Karyotype evolution of Ph positive chronic myelogenous leukemia
patients relapse in advanced phases of the disease after allogeneic
bone marrow transplantation. Cancer Genet Cytogenetic. 57:69–78.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dastugue N, Duchayne E, Huguet F, Demur C,
Plaisancie H, Calvas P, Bourrouillou G, Pris J and Colombies P:
t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid
leukemia. Cancer Genet Cytogenet. 63:37–42. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li L, Ritterbach J, Harbott J, Schroyens
W, Lohmeyer J, Pralle H and Lampert F: Blastic phase chronic
myeloid leukemia with a four-break rearrangement:
t(11;9)(9;22)(q23;p22;q34;q11). Cancer Genet Cytogenet. 68:131–134.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Otero L, Moellmann AC, Pombo-de-Oliveira
MS, Ornellas MH, Pires V, Bouzas LF and Tde Fernandez S: Additional
t(1;11)(p21;q23) with mixed lineage leukemia rearrangement in
T-blastic crisis of a Ph-positive chronic myeloid leukemia. Eur J
Haematol. 79:179–181. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mikhail FM, Sinha KK, Saunthararajah Y and
Nucifora G: Normal and transforming functions of RUNX1: A
perspective. J Cell Physiol. 207:582–593. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Klampfl T, Milosevic JD, Puda A,
Schönegger A, Bagienski K, Berg T, Harutyunyan AS, Gisslinger B,
Rumi E, Malcovati L, et al: Complex patterns of chromosome 11
aberrations in myeloid malignancies Target CBL, MLL, DDB1 and LMO2.
PLoS One. 8:e778192013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dewald G: Interphase fish studies of
chronic myeloid leukemia. In: Molecular cytogenetics: Protocols and
applicationsMethods in molecular biology. Fan YS: 204. Humana
Press; Totowa, NJ: pp. 311–342. 2002, PubMed/NCBI
|
|
23
|
Huntly BJ, Bench A and Green AR: Double
Jeopardy from a single translocation: Deletions of the derivative
chromosome 9 in chronic myeloid leukemia. Blood. 102:1160–1168.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Soverini S, Colarossi S, Gnani A, Rosti G,
Castagnetti F, Poerio A, Iacobucci I, Amabile M, Abruzzese E,
Orlandi E, et al: Contribution of ABL kinase domain mutations to
imatinib resistance in different subsets of Philadelphia-positive
patients: By the GIMEMA 213 Working Party on Chronic Myeloid
Leukemia. Clin Cancer Res. 12:7374–7379. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Redaelli S, Piazza R, Rostagno R,
Magistroni V, Perini P, Marega M, Gambacorti-Passerini C and
Boschelli F: Activity of bosutinib, dasatinib, and nilotinib
against 18 imatinib-resistant bcr/abl mutants. J Clin Oncol.
27:469–471. 2009. View Article : Google Scholar : PubMed/NCBI
|
